What is CVE-2023-37154?

CVE-2023-37154 is a high-severity vulnerability in N/a, classified under Command Injection. CVSS score: 8.4/10. Published 2024-10-09.

How severe is CVE-2023-37154?

High severity. CVSS v3 base score is 8.4 out of 10.

Is CVE-2023-37154 known to be exploited?

1 public proof-of-concept repositories are indexed. Not currently listed in the CISA KEV catalog.

RCE in N/a

CVE-2023-37154

check_by_ssh in Nagios nagios-plugins 2.4.5 allows arbitrary command execution via ProxyCommand, LocalCommand, and PermitLocalCommand with \${IFS}. This has been categorized both as fixed in e8810de, and as intended behavior.

Vulnerability class: Command Injection (OS Command Injection)

EPSS: 0.005 (36.3th percentile) — read the EPSS interpretation.

CVSS v3 metric

CVSS v3 base score 8.4 (High). Vector: CVSS:3.1/AV:L/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H.

Affected products

N/a — versions n/a

Weakness classification (CWE)

CWE-77 — Command Injection

Public proof-of-concept exploits

ARPSyndicate/cve-scores

References

Frequently asked questions

What is CVE-2023-37154?: CVE-2023-37154 is a high-severity vulnerability in N/a, classified under Command Injection. CVSS score: 8.4/10. Published 2024-10-09.
How severe is CVE-2023-37154?: High severity. CVSS v3 base score is 8.4 out of 10.
Is CVE-2023-37154 known to be exploited?: 1 public proof-of-concept repositories are indexed. Not currently listed in the CISA KEV catalog.